Glenn Schoettle, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Memphis, TNNPI 1710996624
Payments from drug & device makers
What this record shows
Medtronic accounts for 64.5% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $1,962 and has fallen 93.6% since, to $126 in 2025.
Across 66 payments — averaging $85.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- W. L. Gore & Associates, Inc.$1K
- Edwards Lifesciences$328
- Surgical Specialties Corporation (US), Inc. (dba Corza Medical)$205
- Elutia, Inc.$145
- Cvrx, Inc.$114
- plus $83 from 3 others
What the payments were for
- Travel & lodging$2,51745%
- Food & beverage$3,10855%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 42 | $3,630 |
| W. L. Gore & Associates, Inc. | 7 | $1,120 |
| Edwards Lifesciences | 6 | $328 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 3 | $205 |
| Elutia, Inc. | 3 | $145 |
| Cvrx, Inc. | 1 | $114 |
| Abiomed | 2 | $52 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
| Lemaitre Vascular, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$1,610
- CoreValve Evolut$1,084
- TAG Thoracic Endoprosthesis$980
- Barostim Neo System$114
How this compares
$5,625 in reported general payments places this provider in the 55th percentile of 115 thoracic surgery (cardiothoracic vascular surgery) providers in Tennessee.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cilostazol | 46 | $1,372 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Memphis
- Harvey GarrettMemphis$712K
- Danielle SenMemphis$52K
- Rachel HarrisonMemphis$36K
- Bradley WolfMemphis$32K
- Edward RobbinsMemphis$31K
- Ganpat ValaulikarMemphis$13K
- Thomas NgMemphis$10K
- Christopher MutrieMemphis$10K
- Grayson WheatleyNashville$900K
- V ReddyNashville$760K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.